These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 29573235

  • 1. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
    Wang Y, Zhang C, Zhang P, Guo G, Jiang T, Zhao X, Jiang J, Huang X, Tong H, Tian Y.
    Cancer Med; 2018 May; 7(5):1670-1679. PubMed ID: 29573235
    [Abstract] [Full Text] [Related]

  • 2. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
    Ghosh S, Bhowmik S, Majumdar S, Goswami A, Chakraborty J, Gupta S, Aggarwal S, Ray S, Chatterjee R, Bhattacharyya S, Dutta M, Datta S, Chowdhury A, Dhali GK, Banerjee S.
    Int J Cancer; 2020 Nov 15; 147(10):2934-2947. PubMed ID: 32441313
    [Abstract] [Full Text] [Related]

  • 3. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN, Youssef AS, El-Desouky ED, Ahmed OS, Lotfy MM, Nassar AA, Bahnassey AA.
    Tumour Biol; 2016 Sep 15; 37(9):12273-12286. PubMed ID: 27271989
    [Abstract] [Full Text] [Related]

  • 4. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
    Tat Trung N, Duong DC, Tong HV, Hien TTT, Hoan PQ, Bang MH, Binh MT, Ky TD, Tung NL, Thinh NT, Sang VV, Thao LTP, Bock CT, Velavan TP, Meyer CG, Song LH, Toan NL.
    PLoS One; 2018 Sep 15; 13(4):e0196081. PubMed ID: 29672637
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
    Sohn W, Kim J, Kang SH, Yang SR, Cho JY, Cho HC, Shim SG, Paik YH.
    Exp Mol Med; 2015 Sep 18; 47(9):e184. PubMed ID: 26380927
    [Abstract] [Full Text] [Related]

  • 7. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
    Zhu HT, Liu RB, Liang YY, Hasan AME, Wang HY, Shao Q, Zhang ZC, Wang J, He CY, Wang F, Shao JY.
    Liver Int; 2017 Jun 18; 37(6):888-896. PubMed ID: 28061012
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
    Wang F, Ying H, He B, Pan Y, Sun H, Wang S.
    Tumour Biol; 2016 Apr 18; 37(4):4945-53. PubMed ID: 26531720
    [Abstract] [Full Text] [Related]

  • 11. Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats.
    Liu WH, Ren LN, Wang X, Wang T, Zhang N, Gao Y, Luo H, Navarro-Alvarez N, Tang LJ.
    J Cancer Res Clin Oncol; 2015 Oct 18; 141(10):1767-78. PubMed ID: 25724413
    [Abstract] [Full Text] [Related]

  • 12. Identification of exosomal hsa-miR-483-5p as a potential biomarker for hepatocellular carcinoma via microRNA expression profiling of tumor-derived exosomes.
    Lin J, Lin W, Bai Y, Liao Y, Lin Q, Chen L, Wu Y.
    Exp Cell Res; 2022 Aug 15; 417(2):113232. PubMed ID: 35659970
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
    Caviglia GP, Abate ML, Gaia S, Petrini E, Bosco C, Olivero A, Rosso C, Ciancio A, Pellicano R, Saracco GM, Rizzetto M, Smedile A.
    Panminerva Med; 2017 Dec 15; 59(4):283-289. PubMed ID: 28650134
    [Abstract] [Full Text] [Related]

  • 17. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
    Zuo D, Chen L, Liu X, Wang X, Xi Q, Luo Y, Zhang N, Guo H.
    Tumour Biol; 2016 May 15; 37(5):6539-49. PubMed ID: 26637228
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients.
    Eldosoky MA, Hammad R, Elmadbouly AA, Aglan RB, Abdel-Hamid SG, Alboraie M, Hassan DA, Shaheen MA, Rushdi A, Ahmed RM, Abdelbadea A, Abdelmageed NA, Elshafei A, Ali E, Abo-Elkheir OI, Zaky S, Hamdy NM, Lambert C.
    Int J Mol Sci; 2023 Feb 05; 24(4):. PubMed ID: 36834570
    [Abstract] [Full Text] [Related]

  • 19. Circulating microRNAs (miR-16, miR-22, miR-122) expression and early diagnosis of hepatocellular carcinoma.
    Fang Y, Yan D, Wang L, Zhang J, He Q.
    J Clin Lab Anal; 2022 Jul 05; 36(7):e24541. PubMed ID: 35666610
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
    Cui Y, Xu HF, Liu MY, Xu YJ, He JC, Zhou Y, Cang SD.
    World J Gastroenterol; 2019 Apr 21; 25(15):1890-1898. PubMed ID: 31057302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.